chrX-111220391-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_002578.5(PAK3):āc.1579A>Gā(p.Ser527Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,203,860 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 76 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002578.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK3 | NM_002578.5 | c.1579A>G | p.Ser527Gly | missense_variant | 18/18 | ENST00000372007.10 | NP_002569.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAK3 | ENST00000372007.10 | c.1579A>G | p.Ser527Gly | missense_variant | 18/18 | 1 | NM_002578.5 | ENSP00000361077 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 22AN: 111421Hom.: 0 Cov.: 22 AF XY: 0.000327 AC XY: 11AN XY: 33603
GnomAD3 exomes AF: 0.000148 AC: 27AN: 182204Hom.: 0 AF XY: 0.000120 AC XY: 8AN XY: 66776
GnomAD4 exome AF: 0.000211 AC: 231AN: 1092385Hom.: 0 Cov.: 27 AF XY: 0.000182 AC XY: 65AN XY: 358061
GnomAD4 genome AF: 0.000197 AC: 22AN: 111475Hom.: 0 Cov.: 22 AF XY: 0.000327 AC XY: 11AN XY: 33667
ClinVar
Submissions by phenotype
Intellectual disability, X-linked 30 Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 20, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Uncertain significance, criteria provided, single submitter | research | TIDEX, University of British Columbia | - | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 04, 2023 | Variant summary: PAK3 c.1579A>G (p.Ser527Gly) results in a non-conservative amino acid change located in the p21-activated kinase 3, catalytic domain (IPR035063) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 204029 control chromosomes (gnomAD), predominantly at a frequency of 0.0012 within the Finnish subpopulation in the gnomAD database, including 9 hemizygotes. c.1579A>G has been reported in the literature in individuals affected with intellectual disability or atypical cerebral palsy (Tzschach_2015, Horvath_2018, Matthews_2018). These reports do not provide unequivocal conclusions about association of the variant with Intellectual Disability, X-Linked 30. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31843706, 29246092, 30542205, 32050918, 25649377). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified this variant as uncertain significance (n=2), likely benign (n=1) and benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign. - |
PAK3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 26, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at